← Leaderboards
Robert B. Dickson
Georgetown University
$4,932,182
Attributed
$4,932,182
Total exposure
7
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$8,970,615 · 8
By mechanism
P50$4,444,303 · 2
R01$2,436,588 · 3
T32$1,739,630 · 1
R21$350,094 · 2
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Chen-Yong Lin$2,606,894
- Moshe Levi$17,675,566
- Alan Paul Kozikowski$7,525,629
- Michael D Johnson$2,313,593
- John L. Marshall$2,076,333
Others in their field
Top investigators on “Breast Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$251,848,784
- Richard L Schilsky · University Of Chicago$110,812,897
- Walter John Curran · Thomas Jefferson University$96,881,565
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$87,504,493
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,613,341
Research focus
Breast NeoplasmsLaboratory MouseNeoplastic ProcessTissue /Cell CultureMammary EpitheliumNeoplasm /Cancer GeneticsTransforming Growth FactorsMetastasisSite Directed MutagenesisCancer PreventionNeoplastic GrowthNeoplasm /Cancer TherapyImmunocytochemistryGenetically Modified AnimalsAngiogenesisNeoplastic CellOncogenesEpidermal Growth FactorProtease InhibitorWestern BlottingsNeoplasm /Cancer InvasivenessApoptosisHuman TissueDisease /Disorder Model
Grant awards (25)
Training Grant in Tumor Biology$450,691
T32 · FY2005 · CA
Transformation of human mammary epithelium by c-Myc$349,200
R01 · FY2005 · AG
Matriptase: Activation and Function in Breast Cancer$258,020
R01 · FY2005 · CA
Training Grant in Tumor Biology$459,536
T32 · FY2004 · CA
Transformation of human mammary epithelium by c-Myc$349,200
R01 · FY2004 · AG
Matriptase: Activation and Function in Breast Cancer$258,020
R01 · FY2004 · CA
SPORE IN BREAST CANCER$94,036
P50 · FY2004 · CA
SPORE IN BREAST CANCER$38,766
P50 · FY2004 · CA
Matriptase: Activation and Function in Breast Cancer$433,020
R01 · FY2003 · CA
TRAINING GRANT IN TUMOR BIOLOGY$428,205
T32 · FY2003 · CA
TRAINING GRANT IN TUMOR BIOLOGY$41,138
T32 · FY2003 · CA
TRAINING GRANT IN TUMOR BIOLOGY$320,879
T32 · FY2002 · CA
ANTI-METALLOPROTEASE THERAPY$135,290
P50 · FY2002 · CA
STEM CELLS IN TRANSGENIC MOUSE MAMMARY TUMORIGENESIS$116,400
R21 · FY2002 · CA
TRAINING GRANT IN TUMOR BIOLOGY$39,181
T32 · FY2002 · CA
SPORE IN BREAST CANCER$37,636
P50 · FY2002 · CA
SPORE IN BREAST CANCER$1,849,494
P50 · FY2001 · CA
APOPTOSIS &MALIGNANT PROGRESSION IN MAMMARY TUMOR CELLS$280,410
R01 · FY2001 · AG
ANTI-METALLOPROTEASE THERAPY$135,290
P50 · FY2001 · CA
STEM CELLS IN TRANSGENIC MOUSE MAMMARY TUMORIGENESIS$116,600
R21 · FY2001 · CA
SPORE IN BREAST CANCER$2,018,501
P50 · FY2000 · CA
APOPTOSIS &MALIGNANT PROGRESSION IN MAMMARY TUMOR CELLS$274,062
R01 · FY2000 · AG
EGF FAMILY INDUCTION OF MAMMARY HYPERPLASIAS AND TUMORS$234,656
R01 · FY2000 · CA
ANTI-METALLOPROTEASE THERAPY$135,290
P50 · FY2000 · CA
NOVEL SERINE PROTEASE IN INVASIVE CARCINOMAS$117,094
R21 · FY2000 · CA